News
18h
Zacks Investment Research on MSNHims & Hers Health, Inc. (HIMS) is a Great Momentum Stock: Should You Buy?Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...
Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the ...
CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.
Stocktwits - Shares of Hims & Hers Health, Inc. (HIMS) surged nearly 16% in Tuesday’s regular session and extended gains in ...
Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report ...
Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...
Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The ...
5d
Zacks Investment Research on MSNIs Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results